IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAF5. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,784,734 | -1.6% | 19,017,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,092,318 | -61.6% | 19,017,000 | -61.6% | 0.00% | -63.6% |
| Q1 2023 | $49,715,028 | -39.7% | 49,517,000 | -35.3% | 0.01% | -42.1% |
| Q4 2022 | $82,494,920 | -1.6% | 76,517,000 | -8.4% | 0.02% | 0.0% |
| Q3 2022 | $83,864,000 | -14.6% | 83,550,000 | -10.3% | 0.02% | -24.0% |
| Q2 2022 | $98,152,000 | -2.8% | 93,100,000 | +3.3% | 0.02% | +19.0% |
| Q1 2022 | $101,021,000 | +1.0% | 90,100,000 | 0.0% | 0.02% | +5.0% |
| Q4 2021 | $100,067,000 | +0.2% | 90,100,000 | +6.2% | 0.02% | -4.8% |
| Q3 2021 | $99,833,000 | +0.3% | 84,800,000 | 0.0% | 0.02% | -4.5% |
| Q2 2021 | $99,519,000 | +6.3% | 84,800,000 | 0.0% | 0.02% | -4.3% |
| Q1 2021 | $93,634,000 | +13.1% | 84,800,000 | +14.9% | 0.02% | +4.5% |
| Q4 2020 | $82,810,000 | +21.9% | 73,800,000 | +7.3% | 0.02% | +15.8% |
| Q3 2020 | $67,923,000 | – | 68,800,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 3,963,000 | $4,557,000 | 0.58% |
| WOLVERINE ASSET MANAGEMENT LLC | 22,267,000 | $25,136,000 | 0.24% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,416,000 | $11,756,000 | 0.23% |
| LINDEN ADVISORS LP | 26,849,000 | $30,767,000 | 0.19% |
| AQR Arbitrage LLC | 5,200,000 | $5,988,000 | 0.16% |
| Jefferies Group LLC | 6,927,000 | $7,825,787 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,700,000 | $14,624,000 | 0.04% |
| HBK INVESTMENTS L P | 7,000,000 | $7,849,000 | 0.03% |
| Calamos Advisors LLC | 7,500,000 | $8,584,000 | 0.03% |
| Citadel Advisors | 90,100,000 | $101,021,000 | 0.02% |